3α,5α-THP: A potential plasma neurosteroid biomarker in Alzheimer's disease and perhaps non-Alzheimer's dementia

Psychopharmacology

Volumn 186, Issue 3, 2006, Pages 481-485

  Smith, Charles D ^a,c   Wekstein, David R ^a   Markesbery, William R ^a   Frye, Cheryl A ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

3 ,5 THP; Allopregnenolone; Alzheimer's disease; Biomarker; Blood; Dementia; Neurosteroid; Plasma

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; BIOLOGICAL MARKER; NEUROSTEROID; ELTANOLONE; ESTRADIOL; PROGESTERONE; TESTOSTERONE DERIVATIVE;

AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; STEROID BLOOD LEVEL; STEROID METABOLISM; VALIDATION PROCESS; BLOOD; CASE CONTROL STUDY; DEMENTIA;

AGED; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEMENTIA; ESTRADIOL; FEMALE; HUMANS; MALE; PREGNANOLONE; PROGESTERONE; TESTOSTERONE CONGENERS;

EID: 33744497811     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0186-1     Document Type: Article

References (13)

1. Baulieu EE, Robel P, Fellous A, Duchossoy Y, Fontaine-Lenoir V, David S (2004) MAPREG: toward a novel approach of neuroprotection and treatment of Alzheimer's disease. J Mol Neurosci 24:63-65
2. Dubrovsky BO (2005) Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog Neuropsychopharmacol Biol Psychiatry 29:169-192
3. Finn DA, Gee KW (1994) The estrus cycle, sensitivity to convulsants and the anticonvulsant effect of a neuroactive steroid. J Pharmacol Exp Ther 271:164-170
4. Frank C, Sagratella S (2000) Neuroprotective effects of allopregnenolone on hippocampal irreversible neurotoxicity in vitro. Prog Neuropsychopharmacol Biol Psychiatry 24:1117-1126
5. Frye CA, Lacey EH (2000) Progestins influence performance on cognitive tasks independent of changes in affective behavior. Psychobiology 8:550-563
6. Frye CA, Scalise TJ, Bayon LE (1998) Finasteride blocks the reduction in ictal activity produced by exogenous estrous cyclicity. J Neuroendocrinol 10:291-296
7. Frye CA, Sturgis JD (1995) Neurosteroids affect spatial/reference, working, and long-term memory of female rats. Neurobiol Learn Mem 64:83-96
8. Herzog AG, Frye CA (2003) Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 53:390-391
9. Maurice T, Urani A, Phan VL, Romieu P (2001) The interaction between neuroactive steroids and the sigmal receptor function: behavioral consequences and therapeutic opportunities. Brain Res Brain Res Rev 37:116-132
10. Rhodes ME, McCormick CM, Frye CA (2004) 3alpha,5alpha-THP mediates progestins' effects to protect against adrenalectomy-induced cell death in the dentate gyrus of female and male rats. Pharmacol Biochem Behav 78:505-512
11. Schumacher M, Weill-Engerer S, Liere P, Robert F, Franklin RJ, Garcia-Segura LM, Lambert JJ, Mayo W, Melcangi RC, Parducz A, Suter U, Carelli C, Baulieu EE, Akwa Y (2003) Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Prog Neurobiol 71:3-29
12. Stoffel-Wagner B (2001) Neurosteroid metabolism in the human brain. Eur J Endocrinol 145:669-679
13. Twist SJ, Taylor GA, Weddell A, Weightman DR, Edwardson JA, Morris CM (2000) Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci Lett 286:1-4